Suzanne Thomas, Ph.D.
Vice President of Research
Suzanne Thomas is VP of Research and is responsible for the construction, testing and preclinical production of Replimune’s developmental products. Suzanne held similar roles at BioVex and subsequently Amgen from 2001-2014 and was instrumental in the development of Imlygic (talimogene laherparepvec) among other programs. Suzanne was a post-doctoral fellow at University College London before joining BioVex and earned a PhD in Virology from the University of Warwick.